The Top Impactful Future Pharma Kickoff Conference was held successfully at the Hilton Hotel in Kuala Lumpur, Malaysia's capital
—
Highlights from the Meeting
Mr. Farzam Kamalabadi, Founder and President of Future Trends Group, Future Pharma Investors, analyzed human health problems in the post-coronavirus era in fluent Chinese, and how "Future Pharma" can provide world-class medical products to people in need during the epidemic as soon as possible.
Population aging is now a common trend affecting countries all over the world. Chairman Farzam Kamalabadi stated that even developed countries must prioritize the sustainability of medical services.
Using Malaysia as an example, statistics show that people over the age of 65 accounted for 10.4% of the population in 2020. Furthermore, public health emergencies such as COVID-19 have claimed the lives of 683 million people worldwide in the past. All at the same, global marketing of some unhealthy products has increased the cases of chronic diseases such as heart disease, hypertension, cancer, and diabetes, and the age of onset is younger. Many young people today are also threatened by various diseases.
Farzam Kamalabadi creatively proposed the [1123] strategy and admitted that Future Pharma has great potential.
1 Motivation-Health for everyone on earth.
1 Single Product-Pfizer Paxlovid.
2．Large Tuyere
1. The once-in-a-century big draught in the post-epidemic era.
2.2024-2025 The fourth wave of the bull market in the field of digital currency.
3 Major Goals
Goal 1. Help 10 million people get spot treatment for novel coronavirus disease
Goal 2. Help 10 million Pfizer Futures members grow their wealth.
Goal 3. The market value of Woodpecker Token WP has increased by 1000 times, creating an Ethereum ecosystem in the global health field.
Future Pharma has huge potential and is expected to boom in 2023.
At the moment, significant changes are occurring in the global medical and health field, such as aging, which is leading to an increase in the incidence of chronic diseases, which is leading to an increase in global medical needs, so innovation and new technologies are critical. Over the last two decades, Future Pharmaceuticals has been the only company that Mr. Farzam Kamalabadi has paid close attention to and personally developed a global development strategy for.
It is worth mentioning that Future Pharma will make a significant entry into the Chinese market in 2022. Future Pharma is dedicated to imagining the future of medicine, improving people's quality of life, and extending humanity's future. Create transformative treatments in areas of high medical and health need by combining innovative science and digital technologies. More importantly, they are supported by an elite top team from around the world, which includes scientists, researchers, information disseminators, production experts, and registration regulatory experts. They understand the pathogenic properties, evolution characteristics, and prevention and control laws of various bacteria or viruses. As a result, they believe that developing innovative medical care is necessary and have the requisite wisdom to deal with various challenges.
Future Pharma hopes to not only provide value to patients but also to fully utilize its light and heat for the healthy development of society. Globally, their products benefit 400 million patients, and future access to medicines programs benefit another 26.2 million. Malaysia has become the first choice for tourists from many countries due to its superior geographical location and climate. More people will benefit from the Malaysia Future Pharma Project's launch.
Future Pharma will take on the responsibility of the times with significantly larger enthusiasm in 2023, taking active actions to promote the pharmaceutical industry's rapid development and contributing to the cause of great health.
About Future Pharma
Founded in 2003 and headquartered in New York, USA, Future Pharma is highly focused focusing on general health and finance fields, including global health industry groups, banks, etc. Future Pharma has gathered talents in the fields of global scientists, researchers, information disseminators, production experts, and registered regulatory experts. After 15 years of development, it has become a world-renowned supplier of anti-tumor drugs, vaccines, anti-aging, regenerative stem cell anti-infection, and innovative drugs.
The headquarter of the group is located in the most prosperous financial district in the United States. The group's Asian branches are located in cities in more than a dozen countries, including Kuala Lumpur in Malaysia, Singapore, Hanoi in Vietnam, Shenzhen, Chengdu, and Indonesia.
Its goal in 2023 is to set up 400 agency offices in more than 20 countries including Hong Kong, Taiwan, Singapore, Vietnam, Thailand, Philippines, Indonesia, Japan, South Korea, India, Brazil, South Africa, Italy, and Spain.
Contact Info:
Name: Cherry Yang
Email: Send Email
Organization: Future pharma
Website: https://twitter.com/FuturePharmaEN
Release ID: 89090012
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
